GenomeNarrator vs Promethease in 2026: Which DNA Analysis Tool Should You Use?
Promethease and GenomeNarrator both analyze 23andMe and AncestryDNA raw data, but they produce very different results. Here's a detailed comparison of features, pricing, report quality, and clinical depth.
Category: Solutions · By GenomeNarrator Team · · 7 min read
If you have raw DNA data from 23andMe or AncestryDNA, you've probably heard of Promethease, one of the earliest third-party genome analysis tools. GenomeNarrator is a newer platform that takes a fundamentally different approach. Here's how they compare.
What Promethease does
Promethease ($12 one-time) cross-references your raw data against SNPedia, a community-edited wiki of genetic variants. It returns a large, searchable list of your variants with associated literature summaries. The output is comprehensive but unstructured: you get hundreds or thousands of entries with "good" and "bad" labels, sorted by magnitude scores that SNPedia editors assign.
What GenomeNarrator does
GenomeNarrator (free preview, or full access from $14.99/month, also available as a $19.99 one-time 30-day pass) analyzes your raw data against multiple clinical databases (ClinVar, the GWAS Catalog, SNPedia, gnomAD, and the PGS Catalog) and produces a structured, multi-section report. Findings are organized by body system, scored with evidence tiers, and include polygenic risk scores, pharmacogenomics (CPIC guidelines), and ACMG secondary findings screening.
Promethease gives a searchable variant list. GenomeNarrator gives a structured PDF report with an executive summary, body-system sections, and clinical recommendations, designed to be shared with a doctor.
Clinical depth
Promethease surfaces SNPedia annotations: useful but community-curated and variable in quality. GenomeNarrator cross-references ClinVar (the NIH gold-standard clinical variant database), runs formal ACMG secondary findings screening across 84 genes, and applies CPIC pharmacogenomics guidelines for 133 gene-drug pairs across 41 genes.
Pharmacogenomics
Promethease shows CYP variants with SNPedia annotations. GenomeNarrator provides structured PGx phenotyping; it determines your metabolizer status for each gene and flags specific medications with AVOID, DOSE CHANGE, or MONITOR alerts following CPIC Level A/B evidence.
Polygenic risk scores
Promethease does not calculate PRS. GenomeNarrator computes polygenic risk scores using validated models from the PGS Catalog for conditions like coronary artery disease, type 2 diabetes, and breast cancer, and shows your percentile relative to the reference population.
Privacy
Promethease processes your data on their servers. GenomeNarrator reads your raw genome file in your browser and never uploads it. Only the genotype calls the analysis needs are sent to our scoring servers, which keep no copy once your results are returned.
When to use Promethease
Promethease is a good fit if you're a genetics enthusiast who wants to explore raw variant data, are comfortable interpreting SNPedia literature yourself, or want a one-time purchase with no subscription.
When to use GenomeNarrator
GenomeNarrator is a better fit if you want a structured clinical-grade report you can share with your doctor, need pharmacogenomics guidance with specific medication flags, want ACMG secondary findings screening, prefer privacy-first processing (browser-based), or want polygenic risk scores with population percentiles.
Verdict
Promethease is a variant explorer. GenomeNarrator is a clinical analysis platform. If you want to browse your genome, Promethease works. If you want to understand your health risks and bring actionable findings to your doctor, GenomeNarrator provides a more structured and clinically relevant output, at a lower price point.
More from GenomeNarrator: all genomics articles, how the analysis works, or GenomeNarrator home.